# RHA® 4 With New Anesthetic - Nasolabial Folds

> **NCT04087395** · NA · COMPLETED · sponsor: **Teoxane SA** · enrollment: 30 (actual)

## Conditions studied

- Aging
- Pain

## Interventions

- **DEVICE:** RHA®4 with new anesthetic agent
- **DEVICE:** RHA®4-Lidocaine

## Key facts

- **NCT ID:** NCT04087395
- **Lead sponsor:** Teoxane SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-30
- **Primary completion:** 2020-02-18
- **Final completion:** 2020-11-09
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04087395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04087395, "RHA® 4 With New Anesthetic - Nasolabial Folds". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04087395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*